Profile picture

Doctor Robin Van Lerberghe

University of Leuven, Leuven (Belgium)
Follow
Biography
Robin Van Lerberghe started his residency in Internal Medicine at KU Leuven in 2022. Since 2024, he has been combining his clinical training with a PhD in Cardiology. His work focuses on cardio‑oncology and heart failure, with a strong emphasis on translational research aimed at bridging the gap between scientific research and clinical practice. Outside his professional activities, Robin is an enthusiastic long‑distance runner with a particular passion for (half) marathons. He is fluent in Dutch, French, and English.
Logo ESC

Contributor content

Dual-hit with sequential isoprenaline and PD-1 blockade in A/J Mice to model immune checkpoint inhibitor-induced myocarditis
Presentation
Dual-hit with sequential isoprenaline and PD-1 blockade in A/J Mice to model immune checkpoint inhibitor-induced myocarditis
Immune checkpoint inhibitor myocarditis and hypophysitis mimicking infective endocarditis
Presentation
Immune checkpoint inhibitor myocarditis and hypophysitis mimicking infective endocarditis